NED TALK 2021: Managing BTK Inhibitor–Related Adverse Events and Improving Adherence

Download All
A virtual Nursing Education Day focused on managing AEs and improving adherence in patients with cancer receiving BTK inhibitors, including live webinars with associated audio podcasts and downloadable slidesets.
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Program Director
Beth Faiman, PhD, MSN, APRN-BC, AOCN
person default
Amy Goodrich, RN, MSN, CRNP-AC
Sandra E. Kurtin, PhD, ANP-C, AOCN
Farrukh T. Awan, MD
Christopher R. Flowers, MD, MS
Nicole Lamanna, MD
John P. Leonard, MD
Julie M. Vose, MD, MBA

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to see strategies to assess and manage adverse events associated with BTK inhibitors from 5 experts in managing patients with hematologic malignancies.


Farrukh T. Awan, MD Christopher R. Flowers, MD, MS Nicole Lamanna, MD John P. Leonard, MD Julie M. Vose, MD, MBA Released: June 9, 2021

Downloadable Slidesets

Download these expert-selected slides on optimal treatment of patients with B-cell malignancies with BTK inhibitors

Beth Faiman, PhD, MSN, APRN-BC, AOCN
Program Director
Released: June 11, 2021

Download these expert-selected slides on optimal management of patients with BTK inhibitor-related adverse events

person default Amy Goodrich, RN, MSN, CRNP-AC Released: June 11, 2021

Download these expert-selected slides on optimal management of patients with BTK inhibitor-related serious adverse events

person default Amy Goodrich, RN, MSN, CRNP-AC Released: June 11, 2021

Download these expert-selected slides on avoiding drug- or food-interaction adverse events with BTK inhibitors

Sandra E. Kurtin, PhD, ANP-C, AOCN Released: June 11, 2021

Download these expert-selected slides on working with patients to manage their BTK inhibitor therapy

Sandra E. Kurtin, PhD, ANP-C, AOCN Released: June 11, 2021

Download this summary slideset with key information on managing adverse events associated with BTK inhibitors and improving adherence.

Beth Faiman, PhD, MSN, APRN-BC, AOCN person default Amy Goodrich, RN, MSN, CRNP-AC Sandra E. Kurtin, PhD, ANP-C, AOCN Released: September 10, 2021

Podcasts

Listen to Beth Faiman, PhD, MSN, APRN-BC, AOCN, provide a nursing-focused overview of BTK inhibitors in the treatment of CLL and other B-cell malignancies including the most recent evidence reported from major oncology conferences.

Beth Faiman, PhD, MSN, APRN-BC, AOCN
Program Director
Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 23, 2021 Expired: July 22, 2022

Listen to Amy Goodrich, RN, MSN, CRNP-AC, provide a nursing-focused overview of managing some of the more common adverse events associated with BTK inhibitors

person default Amy Goodrich, RN, MSN, CRNP-AC Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 23, 2021 Expired: July 22, 2022

Listen to Amy Goodrich, RN, MSN, CRNP-AC, provide a nursing-focused overview of managing serious adverse events associated with BTK inhibitor therapy.

person default Amy Goodrich, RN, MSN, CRNP-AC Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 27, 2021 Expired: July 26, 2022

Listen to Sandra E. Kurtin, PhD, ANP-C, AOCN, discuss managing drug–drug and drug–food interactions to minimize adverse events in patients receiving BTK inhibitors.

Sandra E. Kurtin, PhD, ANP-C, AOCN Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 27, 2021 Expired: July 26, 2022

Listen to Sandra E. Kurtin, PhD, ANP-C, AOCN, discuss strategies for patients to use to avoid adverse events with BTK inhibitor treatment.

Sandra E. Kurtin, PhD, ANP-C, AOCN Registered Nurses: 0.25 Nursing contact hours Physician Assistants: maximum of 0.25 hours of AAPA Category I CME credits Released: July 27, 2021 Expired: July 26, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
BeiGene, Ltd.
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue